Cargando…
Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665258/ http://dx.doi.org/10.1182/blood-2022-170369 |
_version_ | 1784831251826343936 |
---|---|
author | Goel, Shipra Segal, Brahm Griffiths, Elizabeth A. Hernandez-Ilizaliturri, Francisco Torka, Pallawi Cortese, Matthew J Ghione, Paola Nemeth, Michael J. Muhitch, Jason |
author_facet | Goel, Shipra Segal, Brahm Griffiths, Elizabeth A. Hernandez-Ilizaliturri, Francisco Torka, Pallawi Cortese, Matthew J Ghione, Paola Nemeth, Michael J. Muhitch, Jason |
author_sort | Goel, Shipra |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9665258 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The American Society of Hematology. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96652582022-11-16 Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents Goel, Shipra Segal, Brahm Griffiths, Elizabeth A. Hernandez-Ilizaliturri, Francisco Torka, Pallawi Cortese, Matthew J Ghione, Paola Nemeth, Michael J. Muhitch, Jason Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665258/ http://dx.doi.org/10.1182/blood-2022-170369 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Poster Abstracts Goel, Shipra Segal, Brahm Griffiths, Elizabeth A. Hernandez-Ilizaliturri, Francisco Torka, Pallawi Cortese, Matthew J Ghione, Paola Nemeth, Michael J. Muhitch, Jason Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title | Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title_full | Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title_fullStr | Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title_full_unstemmed | Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title_short | Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents |
title_sort | evaluation of antibody and t cell responses to covid-19 vaccination in patients with lymphoid malignancies receiving b cell-depleting agents |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665258/ http://dx.doi.org/10.1182/blood-2022-170369 |
work_keys_str_mv | AT goelshipra evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT segalbrahm evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT griffithselizabetha evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT hernandezilizaliturrifrancisco evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT torkapallawi evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT cortesematthewj evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT ghionepaola evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT nemethmichaelj evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents AT muhitchjason evaluationofantibodyandtcellresponsestocovid19vaccinationinpatientswithlymphoidmalignanciesreceivingbcelldepletingagents |